|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4545 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/4545 | (2013.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Number of the document | 3782624 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20200033.7 |
| Date of filing the European patent application | 2017-04-28 | |
| (97) | Date of publication of the European application | 2021-02-24 |
| (45) | Date of publication and mention of the grant of the patent | 2025-09-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| PA201670281 | 2016-04-29 | DK |
| (72) |
HINSBY, Anders Mørkeberg , DK
JENSEN, Thomas Kirkegaard , DK
Fog-Tonnesen, Cathrine Kolster , DK
PETERSEN, Nikolaj, Havnsøe, Torp , DK
Bornæs, Claus , DK
|
| (73) |
Zevra Denmark A/S ,
Nordre Fasanvej 215, 2000 Frederiksberg,
DK
|
| (54) | ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS |
| ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS |